Fusion Pharmaceuticals Inc (FUSN)

전일 마감가:

$21.46

열려 있는:

$21.52

하루 거래량:

183.17K

시가총액:

$1.83B

수익:

$2.21M

순이익/손실:

$-94.90M

주가수익비율:

-11.15

EPS:

-1.93

순현금흐름:

$-85.69M

1주 성능:

+0.14%

1개월 성능:

+1.27%

6개월 성능:

+431.11%

1년 성능:

+392.22%

1일 변동 폭

$21.45

$21.52

52주 변동 폭

$2.31

$21.58

Fusion Pharmaceuticals Inc Stock (FUSN) Company Profile

명칭

Fusion Pharmaceuticals Inc

부문

Healthcare (1209)

산업

Biotechnology (699)

전화

289 799 0891

주소

270 Longwood Road South, Hamilton

직원

37

트위터

다음 수익 날짜

2024-06-14

최신 SEC 제출 서류

FUSN's Discussions on Twitter

Fusion Pharmaceuticals Inc Stock (FUSN) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-12-27	업그레이드	Raymond James	Outperform → Strong Buy
2023-09-29	개시	Oppenheimer	Outperform
2023-06-23	개시	Raymond James	Outperform
2022-12-01	재개	B. Riley Securities	Buy
2022-11-30	개시	SVB Leerink	Outperform
2022-09-16	개시	Truist	Buy
2022-07-06	개시	William Blair	Outperform
2021-10-19	재개	Morgan Stanley	Overweight
2021-08-26	개시	B. Riley Securities	Buy
2020-07-21	개시	Cowen	Outperform
2020-07-21	개시	Jefferies	Buy
2020-07-21	개시	Wedbush	Outperform

모두보기

Fusion Pharmaceuticals Inc 주식(FUSN)의 최신 뉴스

(FUSN) Technical Pivots with Risk Controls - Stock Traders Daily

Stock Traders Daily

What Kind Of Shareholders Hold The Majority In Fusion Pharmaceuticals Inc.'s (NASDAQ:FUSN) Shares? - Yahoo Movies UK

Yahoo Movies UK

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Brokerages - MarketBeat

MarketBeat

Fusion Pharmaceuticals doses first subject in prostate cancer trial - Clinical Trials Arena

Clinical Trials Arena

Fusion Pharmaceuticals doses first subject in prostate cancer trial - Yahoo Finance

Yahoo Finance

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Rating of “Hold” by Analysts - Defense World

Defense World

Fusion Pharmaceuticals Inc (FUSN) 재무 분석

Fusion Pharmaceuticals Inc (FUSN) 매출 2024

Fusion Pharmaceuticals Inc (FUSN) 순이익 2024

Fusion Pharmaceuticals Inc (FUSN) 현금흐름 2024

Fusion Pharmaceuticals Inc (FUSN) 주당 순이익 2024